Journal of the American College of Surgeons
Volume 197, Issue 6 , Pages 896-901 , December 2003

Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer

  • Anna M Derossis, MD

      Affiliations

    • Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    • ,
  • Jane V Fey, MPH

      Affiliations

    • Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    • ,
  • Hiram S Cody III, MD, FACS

      Affiliations

    • Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    • ,
  • Patrick I Borgen, MD

      Affiliations

    • Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    • Corresponding Author InformationCorrespondence address: Patrick I Borgen, MD, 1275 York Ave, MRI-1026, New York, NY 10021, USA.

Received 18 November 2002 ,Revised 31 July 2003 ,Accepted 6 August 2003.

References 

  1. Veronesi U, Paganelli G, Galimberti V, et al.  Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349:1864–1867
  2. Krag D, Weaver D, Ashikaga T, et al.  The sentinel node in breast cancer—a multicenter validation study. N Engl J Med. 1998;339:941–946
  3. McMasters KM, Tuttle TM, Carlson DJ, et al.  Sentinel lymph node biopsy for breast cancer (a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used). J Clin Oncol. 2000;18:2560–2566
  4. Cabanas R. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456–466
  5. Morton DL. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399
  6. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335—–340
  7. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391–401
  8. Albertini JJ, Lyman GH, Cox C, et al.  Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818–1822
  9. Veronesi U, Paganelli G, Viale G, et al.  Sentinel lymph node biopsy and axillary dissection in breast cancer (results in a large series). J Natl Cancer Inst. 1999;91:368–373
  10. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15:2345–2350
  11. Cody HS, Fey J, Akhurst T, et al.  Complementarity of blue dye and isotope in sentinel node localization for breast cancer (univariate and multivariate analysis of 966 procedures). Ann Surg Oncol. 2001;8:13–19
  12. Martin RCG, Derossis A, Fey J, et al.  Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgery. 2001;130:432–438
  13. Derossis AM, Fey J, Yeung H, et al.  A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg. 2001;193:473–478
  14. National Institutes of Health. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. 1998. Available at: www.nhlbi.nih.gov/guidelines/obesity/practgde.htm
  15. Centers for Disease Control, National Center for Health Statistics. National health interview survey, 1997. Available at: www.cdc.gov/nchs/products/pubs/pubd/hestats/3and4/overweight.htm
  16. Cox CE, Pendas S, Cox JM, et al.  Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645–651
  17. Health implications of obesity. (NIH Consensus Panel). Ann of Intern Med 1985;103:1073–1077
  18. Ingram DM, Huang HY, Catchpole BN, Roberts A. Do big breasts disadvantage women with breast cancer. Aust N Z J Surg. 1989;59:115–117
  19. Hebert JR, Augustine A, Barone J, et al.  Weight, height, and body mass index in the prognosis of breast cancer (early results of a prospective study). Int J Cancer. 1988;42:315–318
  20. Werner RS, McCormick B, Petrek JA, et al.  Arm edema in conservatively managed breast cancer (obesity is a major predictive factor). Radiology. 1991;180:177–184
  21. Larson D, Weinstein M, Goldberg I, et al.  Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys. 1986;12:1575–1582
  22. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368–1377
  23. Ingram D, Nottage E, Ng S, et al.  Obesity and breast disease. Cancer. 1989;64:1049–1053
  24. Trentham-Dietz A, Newcomb PA, Egan KM, et al.  Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control. 2000;11:533–542
  25. Morrow M, Rademaker AW, Bethke KP, et al.  Learning sentinel node biopsy (results of a prospective randomized trial of two techniques). Surgery. 1999;126:714–722
  26. Cox CE, Dupont E, Whitehead GF, et al.  Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J. 2002;8:88–91

☆ No competing interests declared.We are grateful to the Tow Foundation for philanthropic grants supporting the sentinel node programs at Memorial Sloan-Kettering Cancer Center.

PII: S1072-7515(03)00921-9

doi: 10.1016/j.jamcollsurg.2003.08.005

Journal of the American College of Surgeons
Volume 197, Issue 6 , Pages 896-901 , December 2003

Article Tools

* Image Usage & Resolution